PMID: 6967861Jan 1, 1980Paper

The Buckley syndrome: recurring, severe staphylococcal infections, eczema and hyperimmunoglobulinemia E. (author's transl)

Infection
S DaumlingB M Belohradsky

Abstract

Fifteen patients aged between three and 27 years were examined clinically and immunologically. Common to all patients were severe recurring cutaneous and pulmonary staphyloccal infections, chronic eczema, eosinophilia and an extremely elevated serum IgE level. Eight of the patients had in addition facial dysplasia characterised by coarse features, prognathism and poorly formed external ears. Marked osteoporosis, particularly of the vertebral bodies, was observed in eight patients. A constant defect of granulocyte chemotaxis was found in only three patients; fluctuating or constantly normal chemotaxis occurred in six patients. Polycloncal hypergammaglobulinemia was detected in 14 patients, elevated IgD in two patients, a partial T-cell defect in two patients and a history of lack of antibody response in one patient. Therapeutic trails anti-H2 receptor-antihistamines did not produce lasting or satisfactory clinical or immunological results in the pathogenetically unidentified disease.

References

Apr 15, 1978·Lancet·E M SmithwickA J Nahmias
May 1, 1977·The Journal of Clinical Investigation·D G WrightJ I Gallin
Feb 1, 1977·The Journal of Allergy and Clinical Immunology·W L WestonI M Hagen
Jan 1, 1978·Immunological Reviews·R H Buckley, W G Becker
Feb 1, 1979·Clinical Immunology and Immunopathology·W R FriedenbergR C Haselby
Apr 12, 1979·The New England Journal of Medicine·K SchopferS D Douglas
Jul 1, 1979·Radiology·D F MertenH Grossman
Oct 1, 1978·The American Journal of Medicine·C GriscelliM Prunieras
Aug 1, 1978·Archives of Disease in Childhood·A EarhoudiJ F Soothill
Nov 1, 1978·The British Journal of Dermatology·A ReboraC Sacchetti
Dec 1, 1978·European Journal of Pediatrics·G R BurgioA G Ugazio
Jan 1, 1975·The Journal of Clinical Investigation·R H Buckley, S A Fiscus
Jul 1, 1976·Acta paediatrica Scandinavica·G FontanJ A Ojeda
Sep 1, 1976·British Journal of Haematology·J E RepineR D Brunning
May 7, 1966·Lancet·S D DavisR J Wedgwood
Sep 1, 1974·Clinical Immunology and Immunopathology·A S GoldmanE V Dahl
May 2, 1968·The New England Journal of Medicine·R L Baehner, D G Nathan
Apr 1, 1973·Annals of Internal Medicine·R A ClarkC H Kirkpatrick
Feb 1, 1972·The Journal of Allergy and Clinical Immunology·C E ArbesmanK Wicher
Sep 1, 1965·Immunochemistry·G ManciniJ F Heremans

❮ Previous
Next ❯

Citations

Mar 4, 1999·The New England Journal of Medicine·B GrimbacherJ M Puck
Sep 1, 1984·European Journal of Pediatrics·S FanconiW H Hitzig
Oct 3, 2002·Allergy·B GrimbacherS M Holland

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.